NCT04933851View on ClinicalTrials.gov

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

ACT1VATE

ACT1VATE, informed by Acceptance and Commitment Therapy (ACT), will consist of five, 90-minute group-based telemedicine therapy sessions delivered by a Behavioral Health Provider.

BEHAVIORAL

DSME/S

Diabetes self-management education and support (DSME/S) will be delivered by a Certified Diabetes Care and Education Specialist via one-on-one telemedicine format.

Trial Locations (1)

92121

RECRUITING

Scripps Whittier Diabetes Institute, San Diego

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Scripps Whittier Diabetes Institute

OTHER